Anti-fibrotic drugs dealing with pulmonary fibrosis after COVID-19-associated acute respiratory distress syndrome

Anti-fibrotic drugs dealing with pulmonary fibrosis after COVID-19-associated acute respiratory distress syndrome

Bibliographic Details
Main Authors:	Abhijit S Nair, Sai Kaushik Pulipaka, Praveen Kumar Kodisharapu, Asiel Christopher
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	Journal of Acute Disease
Online Access:	http://www.jadweb.org/article.asp?issn=2221-6189;year=2021;volume=10;issue=4;spage=177;epage=178;aulast=Nair

Similar Items

Role of almitrine bismesylate in managing refractory hypoxemia in COVID19 acute respiratory distress syndrome
by: Abhijit S Nair, et al.
Published: (2021-01-01)

Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity
by: Seidai Sato, et al.
Published: (2017-09-01)

Converging pathways in pulmonary fibrosis and Covid-19 - The fibrotic link to disease severity
by: Jenny Wigén, et al.
Published: (2020-11-01)

Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review
by: Yet H. Khor, et al.
Published: (2020-08-01)

The in vivo fibrotic role of FIZZ1 in pulmonary fibrosis.
by: Tianju Liu, et al.
Published: (2014-01-01)

A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
by: Katy M. Roach, et al.
Published: (2018-01-01)

Anti-fibrotic therapy for the treatment of pulmonary sequelae in patients healed by COVID-19
by: Antonio Vitiello, et al.
Published: (2021-01-01)

Fibrotic microtissue array to predict anti-fibrosis drug efficacy
by: Mohammadnabi Asmani, et al.
Published: (2018-05-01)

Anti-fibrotic effects of valproic acid in experimental peritoneal fibrosis.
by: Elerson C Costalonga, et al.
Published: (2017-01-01)

Endostatin in fibrosis and as a potential candidate of anti-fibrotic therapy
by: Zequn Zhang, et al.
Published: (2021-01-01)

Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
by: Bridget F. Collins, et al.
Published: (2019-10-01)

T Cells in Fibrosis and Fibrotic Diseases
by: Mengjuan Zhang, et al.
Published: (2020-06-01)

Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis
by: Takumi Yoshikawa, et al.
Published: (2020-01-01)

Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice.
by: Yan Cai, et al.
Published: (2015-01-01)

Correction to: Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis
by: Takumi Yoshikawa, et al.
Published: (2020-05-01)

Anti-Fibrotic Effects of Low Toxic Microcystin-RR on Bleomycin-Induced Pulmonary Fibrosis: A Comparison with Microcystin-LR
by: Jie Wang, et al.
Published: (2021-06-01)

Computed Tomography Images of Fibrotic Pulmonary Sarcoidosis Leading to Chronic Respiratory Failure
by: Michiru Sawahata, et al.
Published: (2020-01-01)

Anti-fibrotic effect of bovine colostrum in carbon tetrachloride-induced hepatic fibrosis
by: Dong Hyun Sinn, et al.
Published: (2017-06-01)

Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?
by: Alessandro Marchioni, et al.
Published: (2018-03-01)

Modeling Progressive Fibrosis with Pluripotent Stem Cells Identifies an Anti-fibrotic Small Molecule
by: Preethi Vijayaraj, et al.
Published: (2019-12-01)

MicroRNA-328, a Potential Anti-Fibrotic Target in Cardiac Interstitial Fibrosis
by: Weijie Du, et al.
Published: (2016-08-01)

Radiation-induced fibrosis : Characterization of the anti-fibrotic mechanisms displayed by pentoxifylline/vitamin E
by: Hamama, Saad
Published: (2012)

The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
by: Shengguang Wang, et al.
Published: (2021-06-01)

A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis
by: James J DiNicolantonio, et al.
Published: (2021-06-01)

The mechanisms of anti-fibrotic activity through epithelial mesenchymal transition in hepatic fibrosis and SOX2 in pulmonary fibrosis models respectively by a small molecule LF-001
by: Hong-Meng Chuang, et al.
Published: (2018)

Pirfenidone attenuates synovial fibrosis and postpones the progression of osteoarthritis by anti-fibrotic and anti-inflammatory properties in vivo and in vitro
by: Qilu Wei, et al.
Published: (2021-04-01)

Novel Anti-fibrotic Therapies
by: Benita L. McVicker, et al.
Published: (2017-05-01)

Physiopathology and prospectives for therapeutic treatment of pulmonary fibrotic state in COVID-19 patients
by: Antonio Vitiello, et al.
Published: (2021-01-01)

The anti-fibrotic effect of human fetal skin-derived stem cell secretome on the liver fibrosis
by: Xia Yao, et al.
Published: (2020-09-01)

Anti-fibrotic effect of Aliskiren in rats with deoxycorticosterone induced myocardial fibrosis and its potential mechanism
by: Likun Ma, et al.
Published: (2012-05-01)

Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis
by: Jing-Yu Chen, et al.
Published: (2020-06-01)

Acute Respiratory Distress Syndrome Complicated by Amiodarone Induced Pulmonary Fibrosis: Don’t Let Your Guard Down
by: Vipin Kumar Singh, et al.
Published: (2017-04-01)

Pediatric Acute Respiratory Distress Syndrome: Fibrosis versus Repair
by: Daniel eIm, et al.
Published: (2016-03-01)

Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
by: Yasunori Iwata, et al.
Published: (2021-05-01)

The anti-fibrotic effect of inhibition of TGFβ-ALK5 signalling in experimental pulmonary fibrosis in mice is attenuated in the presence of concurrent γ-herpesvirus infection
by: Natalia Smoktunowicz, et al.
Published: (2015-09-01)

Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against <it>Schistosoma mansoni</it>-induced liver fibrosis
by: El-Lakkany Naglaa M, et al.
Published: (2012-01-01)

HGF-Modified Dental Pulp Stem Cells Mitigate the Inflammatory and Fibrotic Responses in Paraquat-Induced Acute Respiratory Distress Syndrome
by: Panpan Geng, et al.
Published: (2021-01-01)

Anti-fibrotic Effects of Cardiac Progenitor Cells in a 3D-Model of Human Cardiac Fibrosis
by: Tom C. L. Bracco Gartner, et al.
Published: (2019-04-01)

Serum Metabolomic Characterization of Liver Fibrosis in Rats and Anti-Fibrotic Effects of Yin-Chen-Hao-Tang
by: Hongyang Zhang, et al.
Published: (2016-01-01)

Myocardial Fibrosis in Heart Failure: Anti-Fibrotic Therapies and the Role of Cardiovascular Magnetic Resonance in Drug Trials
by: Matthew Webber, et al.
Published: (2020-08-01)